Abstract
Local intra-arterial fibrinolysis (LIF) is a promising therapeutic option for CRAO. However, the narrow time window of 6 h has greatly limited the application of LIF. In this study, we explored the efficacy of LIF beyond the conventional time windows and compared the result with conservative therapy. This prospective study included 179 CRAO patients with baseline visual acuity (VA) ≤ 20/400 treated at Renmin Hospital of Wuhan University. The mean time from vision loss to presentation was 5.5 days. 58 patients received conventional standard therapy (CST) alone.121 patients underwent LIF. Main outcome was VA improvement ≥ 0.3 logMAR. Secondary outcome was a favorable VA outcome of 20/200 or better. Logistic regressions were performed to identify predictors of visual improvement. 43% patients in the LIF group experienced VA improvement versus 19% with CST (P = 0.002). LIF was associated with 4.0-fold higher likelihood of visual improvement compared to CST (P = 0.001). Poor baseline VA (light perception or no light perception) and shortened prothrombin time (PT) were associated with greater chance of visual improvement with LIF. However, LIF showed no significant advantage over CST for favorable VA outcomes. No major complications occurred. LIF beyond the therapeutic time window improved vision in functionally blind CRAO patients and showed better efficacy when compared with CST. PT may be a potential predictor of visual outcome after LIF. Our findings could complement existing time-based treatment guidelines and potentially allow for personalized decisions on the use of LIF beyond time windows.
Similar content being viewed by others
Data availability
Anonymized data that is not presented in this article may be made available upon reasonable request to qualified researchers for the purposes of reproducing the study procedures and results.
References
Park SJ, Choi NK, Seo KH, Park KH, Woo SJ (2014) Nationwide incidence of clinically diagnosed central retinal artery occlusion in Korea, 2008 to 2011. Ophthalmology 121:1933–1938
Hayreh SS, Zimmerman MB (2005) Central retinal artery occlusion: visual outcome. Am J Ophthalmol 140:376–391
Hayreh SS (2014) Ocular vascular occlusive disorders: natural history of visual outcome. Prog Retin Eye Res 41:1–25
Hayreh SS (2011) Acute retinal arterial occlusive disorders. Prog Retin Eye Res 30:359–394
Weger M, Pichler T, Franke GH, Haas A, Thaler HV, Kraigher-Krainer N, Groselj-Strele A, Wedrich A, Rabensteiner DF (2014) Assessment of vision-related quality of life in patients with central retinal artery occlusion. Retina 34:539–545
Lin JC, Song S, Ng SM, Scott IU, Greenberg PB (2023) Interventions for acute non-arteritic central retinal artery occlusion. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD001989.pub3
Schrag M, Youn T, Schindler J, Kirshner H, Greer D (2015) Intravenous fibrinolytic therapy in central retinal artery occlusion: a patient-level meta-analysis. JAMA Neurol 72:1148–1154
Youn TS, Lavin P, Patrylo M, Schindler J, Kirshner H, Greer DM, Schrag M (2018) Current treatment of central retinal artery occlusion: a national survey. J Neurol 265:330–335
Schmidt DP, Schulte-Mönting J, Schumacher M (2002) Prognosis of central retinal artery occlusion: local intraarterial fibrinolysis versus conservative treatment. Am J Neuroradiol 23:1301–1307
Aldrich EM, Lee AW, Chen CS, Gottesman RF, Bahouth MN, Gailloud P, Murphy K, Wityk R, Miller NR (2008) Local intraarterial fibrinolysis administered in aliquots for the treatment of central retinal artery occlusion: the Johns Hopkins Hospital experience. Stroke 39:1746–1750
Hu H, Zhang B, Zhao Y, Zhou H, Chen H, Yan S (2021) Efficacy of intra-arterial thrombolysis for acute central retinal artery occlusion: a meta-analysis. Eur Neurol 85:186–194
Huang L, Wang Y, Zhang R (2023) Efficacy and safety of intra-arterial thrombolysis in patients with central retinal artery occlusion: a systematic review and meta-analysis. Graefes Arch Clin Exp Ophthalmol 261:103–113
Weber J, Remonda L, Mattle HP, Koerner U, Baumgartner RW, Sturzenegger M, Ozdoba C, Koerner F, Schroth G (1998) Selective intra-arterial fibrinolysis of acute central retinal artery occlusion. Stroke 29:2076–2079
Rudkin AK, Lee AW, Chen CS (2009) Central retinal artery occlusion: timing and mode of presentation. Eur J Neurol 16:674–677
Shah R, Gilbert A, Melles R, Patel A, Do T, Wolek M, Vora RA (2023) Central retinal artery occlusion: time to presentation and diagnosis. Ophthalmol Retina 7:527–531
Ahn SJ, Kim JM, Hong JH, Woo SJ, Ahn J, Park KH, Han MK, Jung C (2013) Efficacy and safety of intra-arterial thrombolysis in central retinal artery occlusion. Invest Ophthalmol Vis Sci 54:7746–7755
Kim HM, Park YJ, Park KH, Woo SJ (2019) Visual field defects and changes in central retinal artery occlusion. PLoS ONE 14:e0209118
Ko SJ, Shin IC, Kim DW, Choi SS, Yang YS (2021) Safety and efficacy of selective intra-arterial thrombolysis for central retinal artery occlusion. Korean J Ophthalmol 35:261–271
Mercier J, Kastler A, Jean B, Souteyrand G, Chabert E, Claise B, Pereira B, Gabrillargues J (2015) Interest of local intra-arterial fibrinolysis in acute central retinal artery occlusion: clinical experience in 16 patients. J Neuroradiol 42:229–235
Schumacher M, Schmidt D, Wakhloo AK (1993) Intra-arterial fibrinolytic therapy in central retinal artery occlusion. Neuroradiology 35:600–605
Scott IU, Campochiaro PA, Newman NJ, Biousse V (2020) Retinal vascular occlusions. The Lancet 396:1927–1940
Biousse V, Nahab F, Newman NJ (2018) Management of acute retinal ischemia: follow the guidelines! Ophthalmology 125:1597–1607
Lange C, Feltgen N, Junker B, Schulze-Bonsel K, Bach M (2009) Resolving the clinical acuity categories “hand motion” and “counting fingers” using the Freiburg visual acuity test (FrACT). Graefes Arch Clin Exp Ophthalmol 247:137–142
Raber FP, Gmeiner FV, Dreyhaupt J, Wolf A, Ludolph AC, Werner JU, Kassubek J, Althaus K (2023) Thrombolysis in central retinal artery occlusion: a retrospective observational study. J Neurol 270:891–897
Schultheiss M, Härtig F, Spitzer MS, Feltgen N, Spitzer B, Hüsing J, Rupp A, Ziemann U, Bartz-Schmidt KU, Poli S (2018) Intravenous thrombolysis in acute central retinal artery occlusion—a prospective interventional case series. PLoS ONE 13:e0198114
Page PS, Khattar NK, White AC, Cambon AC, Brock GN, Rai SN, James RF (2018) Intra-arterial thrombolysis for acute central retinal artery occlusion: a systematic review and meta-analysis. Front Neurol 9:76
Dumitrascu OM, Newman NJ, Biousse V (2020) Thrombolysis for central retinal artery occlusion in 2020: time is vision! J Neuroophthalmol 40:333–345
Shahjouei S, BavarsadShahripour R, Dumitrascu OM (2023) Thrombolysis for central retinal artery occlusion: an individual participant-level meta-analysis. Int J Stroke. https://doi.org/10.1177/17474930231189352
Hayreh SS, Zimmerman MB, Kimura A, Sanon A (2004) Central retinal artery occlusion: retinal survival time. Exp Eye Res 78:723–736
Hayreh SS, Jonas JB (2000) Optic disk and retinal nerve fiber layer damage after transient central retinal artery occlusion: an experimental study in rhesus monkeys. Am J Ophthalmol 129:786–795
McLeod D, Beatty S (2015) Evidence for an enduring ischaemic penumbra following central retinal artery occlusion, with implications for fibrinolytic therapy. Prog Retin Eye Res 49:82–119
Ahn SJ, Park KH, Ryoo NK, Hong JH, Jung C, Yoon CH, Han MK, Woo SJ (2015) No-reflow phenomenon in central retinal artery occlusion: incidence, risk factors, and clinical implications. PLoS ONE 10:e0142852
Ahn SJ, Woo SJ, Park KH, Jung C, Hong JH, Han MK (2015) Retinal and choroidal changes and visual outcome in central retinal artery occlusion: an optical coherence tomography study. Am J Ophthalmol 159:667–676
Augsburger JJ, Magargal LE (1980) Visual prognosis following treatment of acute central retinal artery obstruction. Br J Ophthalmol 64:913
Trudzinski FC, Minko P, Rapp D et al (2016) Runtime and aPTT predict venous thrombosis and thromboembolism in patients on extracorporeal membrane oxygenation: a retrospective analysis. Ann Intensive Care 6:66
Hron G, Eichinger S, Weltermann A, Quehenberger P, Halbmayer WM, Kyrle PA (2006) Prediction of recurrent venous thromboembolism by the activated partial thromboplastin time. J Thromb Haemost 4:752–756
Walsh PN, Kansu T, Savino PJ, Schatz NJ, Magargal LE, Goldberg RE, Corbett JJ (1979) Platelet coagulant activities in arterial occlusive disease of the eye. Stroke 10:589–594
Tandon M, Sheemar A, Bhatnagar K, Meena S, Shakrawal J (2023) Central retinal artery occlusion in rhino-orbital-cerebral mucormycosis: an inflammatory-prothrombotic state. Asia Pac J Ophthalmol (Phila) 12:16–20
Mac Grory B, Lavin P, Kirshner H, Schrag M (2020) Thrombolytic therapy for acute central retinal artery occlusion. Stroke 51:687–695
Schumacher M, Schmidt D, Jurklies B et al (2010) Central retinal artery occlusion: local intra-arterial fibrinolysis versus conservative treatment, a multicenter randomized trial. Ophthalmology 117:1367-1375.e1
Arthur A, Aaron S (2011) Thrombolysis for artery occlusion. Ophthalmology 118:604
Acknowledgements
We express our gratitude to Dr. Mingchang Li, Dr. Shenqi Zhang and Dr. Jianming Liao for performing the LIF procedure for CRAO patients. We thank all the patients who participated in the study.
Funding
This study was funded by Key Research and Development Project of Hubei Province (2022BCA009) to Xuan Xiao, Wuhan University Specific Fund for Major School-level Internationalization Initiatives (WHUGJZDZX-PT02) to Xuan Xiao and Key Laboratory Open Project of Hubei Province (2021KFY056) to Ting Chen.
Author information
Authors and Affiliations
Contributions
Conceptualization: XL, TC, AY, XX; Data curation: XL, TC, CW; Funding acquisition: XX; Investigation: YL, CW, AY; Methodology: XL, YL, YW, YW; Project administration: XX; Resources: YL, YW, YW; Supervision: TC, XX; Visualization: CW, YW, YW; Writing—original draft: XL, TC; Writing—review and editing: XL, YL, CW, AY, XX. All authors have read and agreed to the published version of the manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
The authors have no conflicts of interest to declare.
Ethical approval
The study was approved by the Institutional Review Board of Renmin Hospital of Wuhan University (2020-X-58 and WDRY2022-K278).
Informed consent
All participants gave written informed consent before participation, according to the Declaration of Helsinki.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Li, X., Chen, T., Li, Y. et al. Improved visual outcomes of central retinal artery occlusion with local intra-arterial fibrinolysis beyond the conventional time window. J Thromb Thrombolysis 57, 503–511 (2024). https://doi.org/10.1007/s11239-023-02927-2
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11239-023-02927-2